CCL22 was described initially as a constitutively produced, thymus-specific chemokine, implicated in the recruitment of T cells. One of the functions of CCL22 originally described was induction of migration of CCR4+ Th2 cells, but it has additionally been shown to regulate migration of Tregs. CCL22 has been implicated in a number of diseases, including allergen-induced lung inflammation, atopic dermatitis, and lymphoma. Similarly, a presumed role for CCR4+ cells has been suggested for endotoxic shock, rheumatoid arthritis, T cell lymphoma, and autoimmune diabetes
Alternative Names
Abcd1 ; Scya22 ; C-C motif chemokine 22 ; Activated B and dendritic cell-derived ; CC chemokine ABCD-1 ; Small-inducible cytokine A22
Quantity
20 µg
Regulatory
RUO
Source
E. coli
Host
Mouse
Endotoxin Level
<1.0 EU/μg of recombinant protein as determined by the LAL method.
Biological Activity Comment
Determined by its ability to chemoattract human T cells using a concentration range of 10-50 ng/mL.
Weight
8.0 kDa
Description
A quick spin of the vial followed by reconstitution in distilled water to a concentration not less than 0.1 mg/mL. This solution can then be diluted into other buffers.
Format
Lyophilized PowderRecombinant mouse CCL22 is presented as 0.2 μm filtered PBS pH 7.5.
Purity
>95% as determined by SDS-PAGE
Storage
Upon reconstitution, this cytokine can be stored in working aliquots at 2° - 8°C for one month, or at -20°C for six months.